⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Nitazoxanide

نیتازوکسانید

⚠ Unverified

🐛 Antiparasitic Products, Insecticides And RepellentsAntiprotozoal

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Use with caution 👶 Children:Use with caution 👴 Older adults:Use with caution 🇮🇷 Not found in Iran list ⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA021498 ATC P01AX11

Market / country: 🇺🇸 USA

Alinia (US)

🧮 Dose calculator

Disease / regimen

Diarrhea caused by Giardia lamblia · Regimen source: FDA Alinia · 2.1, Table 1 FDA Alinia · 1

• With food every 12 h for 3 days. Do not give tablets at 11 years or younger (one tablet exceeds the dose). FDA Alinia · 2.1, Table 1 FDA Alinia · 2.1

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Prior hypersensitivity to nitazoxanide or any ingredient. FDA Alinia · 4.1

Formulations

100 mg / 5 mL — suspension 🇺🇸 USA FDA Alinia · 3.2
500 mg tablet — tablet 🇺🇸 USA FDA Alinia · 3.1

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Alinia · 8.1
“Risk Summary There are no data with ALINIA in pregnant women to inform a drug-associated risk.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Alinia · 8.2
“Risk Summary No information regarding the presence of nitazoxanide in human milk, the effects on the breastfed infant, or the effects on milk production is available.”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Alinia · 8.4
“The safety and efficacy of ALINIA for Oral Suspension for the treatment of diarrhea caused by G. lamblia or C. parvum in pediatric patients 1 to 11 years of age has been established based on three (3) randomized, controlled studies with 104 pediatric subjects treated with ALINIA for Oral Suspension 100 mg/5 mL.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Alinia · 8.5
“Clinical studies of ALINIA Tablets and ALINIA for Oral Suspension did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)NDA021498
DailyMed (FDA label)FDA Alinia
MedlinePlus (NIH)Nitazoxanide
WHO ATC/DDDP01AX11
Darooyab (Iran)Nitazoxanide

🇮🇷 Not found in Iran list Darooyab · G-1139/Nitazoxanide

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Alinia · 3.2 FDA Alinia · 3.1 FDA Alinia · 2.1, Table 1 FDA Alinia · 1 FDA Alinia · 2.1 FDA Alinia · 4.1 FDA Alinia · 8.1 FDA Alinia · 8.2 FDA Alinia · 8.4 FDA Alinia · 8.5 FDA Alinia · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1139/Nitazoxanide
Clinical review⚠ Unverified

🔗 Similar drugs

For the same diseases

Tinidazole